Get Started Free
Home›Medical Devices›Baxter International
Baxter International logo
Baxter International
Medical Devices

Baxter International Company Overview

Baxter International logo

Baxter International

● Active
Medical Devices · Deerfield, IL · Est. 1931
Medical DevicesHospital ProductsRenal CareInfusion Therapy↗ Website
$6.2B
Valuation
$11.5B
Revenue
40k+
Employees
1931
Founded

Baxter International is a global medical products and services company that develops and manufactures essential hospital and renal care products, including IV therapies, infusion systems, nutrition therapies, and dialysis equipment. Baxter serves patients in hospital, home, and clinical settings across more than 100 countries, with a core mission of saving and sustaining lives through life-critical therapies.

Recent Press
5 items
Press Release·2026-02-12
Baxter Reports Fourth-Quarter 2025 Results; Sales From Continuing Operations Reach $2.97 Billion
Baxter reported Q4 2025 sales from continuing operations of $2.97 billion, an 8% increase on a reported basis, as the company continues executing its strategic plan following the completion of the Vantive kidney care spin-off.
Press Release·2025-12-03
Baxter Announces Early Tender Results for Senior Notes Offering as Part of Debt Retirement Initiative
Baxter announced early tender results for its cash tender offers to retire its 2.600% senior notes due 2026 and 1.915% senior notes due 2027, as part of a broader initiative to optimize its capital structure and reduce near-term debt obligations.
Press Release·2025-10-28
Baxter Reports Third-Quarter 2025 Results; Launches Welch Allyn Connex 360 Vital Signs Monitor
Baxter reported Q3 2025 worldwide sales of $2.84 billion, up 5%, and launched the Welch Allyn Connex 360, a next-generation patient monitoring device offering advanced connectivity, customizable configurations, and upgrade capabilities.
Press Release·2025-07-30
Baxter Reports Second-Quarter 2025 Results; Company Exceeds Top-Line Guidance
Baxter reported Q2 2025 worldwide sales from continuing operations above previously announced guidance, driven by better-than-expected performance in Medical Products & Therapies and Healthcare Systems & Technologies segments.
Acquisition·2025-04-30
Baxter Reports First-Quarter 2025 Results; Q1 Sales Reach $2.63 Billion as Company Completes Vantive Sale
Baxter reported Q1 2025 worldwide sales from continuing operations of approximately $2.63 billion, up 5% on both a reported and operational basis, following the February 2025 completion of the sale of its Kidney Care business to Carlyle for approximately $3.4 billion.
Company History
10 milestones
Donald Baxter founded the company in Illinois as a pioneer in commercially preparing IV solutions, making life-saving therapy accessible outside major urban hospital compounding pharmacies.

Baxter International Organization Structure & Team

Org Chart
40,000 employees · Click a leader to explore their team
17,830 across 12 departments
Chief Executive Officer
José E. Almeida
Joel Grade — Departments
· 17830 people across 12 depts

Baxter International Financials, Revenue & Market Share

Annual Revenue
$11.5B
+2% vs prior year
YoY Growth
+2%
From $12.8B to $11.5B
Revenue / Employee
$282K
Annual revenue per full-time employee
Revenue Growth
2021
2022
2023
2024
2025
$12.8B
$15.1B
$14.8B
$11.3B
$11.5B
Market Share
IV Solutions & Large Volume Parenterals
22%
share
Baxter International
22%
BD (Becton Dickinson)
18%
ICU Medical
14%
Stryker (medical/beds)
13%
Fresenius Kabi
12%
$180B
TAM
$48B
SAM
$11.3B
SOM
Revenue Streams
IV Solutions & Nutritional Therapies38%
Infusion Systems & Pumps28%
Surgical & Acute Care Products22%
Services & Connected Care12%
Business Units
Hospital Products62%
Baxter's core segment covering IV solutions, infusion pumps, nutritional therapies, and premixed drug products sold to acute care hospitals, surgery centers, and outpatient clinics globally.
Smart Patient Care (Hillrom)38%
Products and services from the 2021 Hillrom acquisition including smart hospital beds, patient monitoring, and clinical communications platforms sold to health systems worldwide.

Baxter International Internal Tools & Processes

Internal Tools
12 departments
Research & Development1800 people · 3 roles
Standards & Certifications
10 standards
Compliance frameworks, security audits, and quality certifications this company maintains.
Quality
ISO 13485
Certified
Baxter's medical device manufacturing sites, including its infusion pump and IV solution facilities, are certified to ISO 13485, the international quality management system standard for medical device design, production, and post-market surveillance.
Regulatory
FDA 21 CFR Part 820
Compliant
Baxter's U.S. medical device operations comply with FDA Quality System Regulation (21 CFR Part 820), governing design controls, production processes, and complaint handling for its infusion pumps, smart beds, and patient monitoring equipment.
Regulatory
cGMP (21 CFR Parts 210/211)
Compliant
Baxter's pharmaceutical manufacturing sites, including IV solution and premixed drug production facilities, operate under FDA current Good Manufacturing Practice regulations to ensure sterility, purity, and potency of parenteral drug products.
Privacy
HIPAA
Compliant
Baxter's connected care and patient monitoring platforms, including Welch Allyn Connex and CareAware, are designed to comply with HIPAA Privacy and Security Rules, protecting patient health information transmitted through hospital networks.
Safety
ISO 14971
Certified
Baxter applies ISO 14971 risk management processes across its medical device portfolio — including the Spectrum IQ and Novum IQ infusion pump families — to systematically identify, evaluate, and control patient safety risks throughout the device lifecycle.
Quality
IEC 62304
Certified
Baxter's medical device software development, including Dose Error Reduction Software (DERS) for its infusion pump platforms and CareAware clinical communications, follows IEC 62304 software lifecycle processes required for Class B and Class C medical device software.
Environmental
ISO 50001
Compliant
Baxter has implemented energy management systems aligned with ISO 50001 at key manufacturing sites as part of its 2030 sustainability commitments to reduce energy intensity and greenhouse gas emissions across its global operations.
Regulatory
EU MDR (2017/745)
Compliant
Baxter's medical devices sold in the European Union comply with the EU Medical Device Regulation (MDR 2017/745), including conformity assessment, clinical evidence requirements, and registration in the European EUDAMED database for infusion systems and patient monitoring products.
Safety
IEC 60601-1
Certified
Baxter's electrically powered medical devices, including its Spectrum IQ infusion pumps, Novum IQ syringe pumps, and Hillrom-brand patient monitoring platforms, are designed and tested to meet IEC 60601-1 electrical safety and essential performance requirements.
Security
SOC 2 Type II
Certified
Baxter's connected care software platforms, including CareAware and Voalte mobile communication systems, maintain SOC 2 Type II certification, demonstrating that security, availability, and confidentiality controls protecting hospital customer data meet independent audit standards.

Baxter International Interview Preparation

Interview Prep
Role-specific interview questions and keywords. Select a department, then click any role to prepare.
Research & Development· 3 roles

Baxter International Products & Competitors

Product Suite
5 products · select one to explore
Medical Devices
Hardware
Hillrom Centrella Smart Bed
A connected hospital bed that works as hard as your care team.

The Centrella Smart Bed is Baxter's flagship acute care hospital bed platform, featuring integrated patient weight scale, exit detection, head-of-bed angle monitoring, and Nurse Call system integration. The Centrella connects to hospital EHRs and the Baxter CareAware platform to automate nursing documentation, enhance fall prevention protocols, and support nurse workflow efficiency in med-surg and telemetry units.

Use Cases
Using Centrella's continuous weight monitoring and head-of-bed angle alerts to support aspiration pneumonia prevention protocols in ventilated patients on the ICU step-down unitConfiguring Centrella exit alerts integrated with the Nurse Call system to flag high fall-risk patients attempting to leave the bed without staff notification in a 40-bed med-surg unitConnecting Centrella beds to Epic through the Baxter CareAware interface engine to automatically document patient weight, bed position, and siderail status in nursing flowsheets
No image
Key Customers
ASC
Ascension Health
TH
Trinity Health
AAH
Advocate Aurora Health
Competitive Intelligence
VSStryker InTouch Critical Care Bed
THEM

Stryker's InTouch bed is a critical care platform featuring integrated scale, turn assist, and nurse communication systems designed for ICU and step-down unit patients requiring frequent repositioning and monitoring.

EDGE

Centrella's EHR integration capabilities and CareAware middleware connectivity give it a stronger workflow automation story in health systems heavily invested in Epic or Cerner

VSLinet Eleganza Smart Bed
THEM

Linet's Eleganza is a European-designed smart bed with integrated monitoring, electronic height adjustment, and care communication features increasingly marketed to U.S. health systems.

EDGE

Established U.S. install base and domestic service infrastructure give Baxter Hillrom a lower implementation risk profile for large health system fleet replacements

VSArjoHuntleigh Endeavour Bed
THEM

Arjo's Endeavour is a hospital bed system designed for pressure injury prevention with lateral tilt, microclimate management, and patient handling features for high-acuity inpatient settings.

EDGE

Baxter Centrella's nurse workflow automation and broader connected care ecosystem differentiate it from Arjo's primarily pressure-injury-focused positioning